With antibiotic resistant bacteria becoming prevalent, reaching high levels, scientists are studying ways to counteract and address this serious problem. Using the drug resistant bacteria that causes Tuberculosis, researchers are testing a new therapy using antimicrobial peptides to overcome this. This research was presented at the 247th National Meeting & Exposition of the American Chemical Society (ACS).
The TB bacteria is slowly coming up with resistant strains that pose a real serious health risk. Scientists have developed a new way to destroy these organisms and similar ones that have built a resistance to antibiotics; drilling.
Using protein engineered antimicrobial peptides (AMP), the outer membrane of bacterial organisms are broken down removing its structural support and protection mechanism. Just like drill bits, the AMPs drill into the thick walls of the cells killing the bacteria. Using three synthesised strains of AMP, lab tests show that all three of these antimicrobial peptides were successful in killing the Mycobacterium tuberculosis and M. smegmatis bacteria .
This is just the first generation of AMPs produced and scientists are also studying another class of AMPs, picidin a and 3, to improve and expand its arsenal against this deadly trend.
The TB bacteria is slowly coming up with resistant strains that pose a real serious health risk. Scientists have developed a new way to destroy these organisms and similar ones that have built a resistance to antibiotics; drilling.
Using protein engineered antimicrobial peptides (AMP), the outer membrane of bacterial organisms are broken down removing its structural support and protection mechanism. Just like drill bits, the AMPs drill into the thick walls of the cells killing the bacteria. Using three synthesised strains of AMP, lab tests show that all three of these antimicrobial peptides were successful in killing the Mycobacterium tuberculosis and M. smegmatis bacteria .
This is just the first generation of AMPs produced and scientists are also studying another class of AMPs, picidin a and 3, to improve and expand its arsenal against this deadly trend.

















